Affinity Asset Advisors, LLC
- SEC CIK
- 0001773195
- Latest filing
- Aug 13, 2026
AVTX holding history
Avalo Therapeutics, Inc. in every 13F filed by Affinity Asset Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AVTX overviewAll 13F holders of AVTXFull Q2 2026 holdings
- Shares (Q2 2026)
- 2,900,000
- Value
- $53.6M
- % of portfolio
- 2.6%
- Quarters held
- 10
- Since Q1 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 2,900,000 | $53.6M | 2.6% | +1,559,160+116.3% | Added | Holders |
| Q1 2026 | 1,340,840 | $20.0M | 1.2% | +289,786+27.6% | Added | Holders |
| Q4 2025 | 1,051,054 | $19.1M | 1.4% | +44,837+4.5% | Added | Holders |
| Q3 2025 | 1,006,217 | $12.8M | 1.2% | +398,345+65.5% | Added | Holders |
| Q2 2025 | 607,872 | $3.03M | 0.4% | −49,282−7.5% | Reduced | Holders |
| Q1 2025 | 657,154 | $5.26M | 0.8% | +106,389+19.3% | Added | Holders |
| Q4 2024 | 550,765 | $4.09M | 0.6% | +505,765+1,123.9% | Added | Holders |
| Q3 2024 | 45,000 | $425.7K | 0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 45,000 | $561.1K | 0.1% | +35,000+350.0% | Added | Holders |
| Q1 2024 | 10,000 | $217.5K | <0.1% | +10,000 | New | Holders |